Skip to content
10-Q

Quarterly Report

Dicerna Pharmaceuticals Inc

0001399529-21-000158

← back to feed
Filed
Nov 9, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 4, 2021 77.89M sh
Shares Diluted Q3 2021 · Sep 30, 2021 77.75M sh
Shares Diluted Q3 2021 · Sep 30, 2021 77.02M sh
Shares Diluted Q3 2021 · Sep 30, 2020 74.52M sh
Shares Diluted Q3 2021 · Sep 30, 2020 73.82M sh
Capex Q3 2021 · Sep 30, 2021 $8.24M
Capex Q3 2021 · Sep 30, 2020 $7.49M
Operating Cash Flow Q3 2021 · Sep 30, 2021 $68.35M
Operating Cash Flow Q3 2021 · Sep 30, 2020 $222.42M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $165.76M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $126.02M
Cash And Equivalents Q3 2021 · Sep 30, 2020 $204.28M
Stockholders Equity Q3 2021 · Sep 30, 2021 $107.66M
Stockholders Equity Q3 2021 · Jun 30, 2021 $111.07M
Stockholders Equity Q3 2021 · Mar 31, 2021 $126.4M
Stockholders Equity Q3 2021 · Dec 31, 2020 $137.75M
Stockholders Equity Q3 2021 · Sep 30, 2020 $153.7M
Stockholders Equity Q3 2021 · Jun 30, 2020 $162.17M
Stockholders Equity Q3 2021 · Mar 31, 2020 $177.91M
Stockholders Equity Q3 2021 · Dec 31, 2019 $152.2M
Current Liabilities Q3 2021 · Sep 30, 2021 $239.3M
Current Liabilities Q3 2021 · Dec 31, 2020 $177.94M
Total Liabilities Q3 2021 · Sep 30, 2021 $664.4M
Total Liabilities Q3 2021 · Dec 31, 2020 $570.09M
Current Assets Q3 2021 · Sep 30, 2021 $589M
Current Assets Q3 2021 · Dec 31, 2020 $618.7M
Total Assets Q3 2021 · Sep 30, 2021 $772.06M
Total Assets Q3 2021 · Dec 31, 2020 $707.85M
Eps Diluted Q3 2021 · Sep 30, 2021 −$0.22
Eps Diluted Q3 2021 · Sep 30, 2021 −$1.14
Eps Diluted Q3 2021 · Sep 30, 2020 −$0.29
Eps Diluted Q3 2021 · Sep 30, 2020 −$1.03
Eps Basic Q3 2021 · Sep 30, 2021 −$0.22
Eps Basic Q3 2021 · Sep 30, 2021 −$1.14
Eps Basic Q3 2021 · Sep 30, 2020 −$0.29
Eps Basic Q3 2021 · Sep 30, 2020 −$1.03
Sga Expense Q3 2021 · Sep 30, 2021 $21.99M
Sga Expense Q3 2021 · Sep 30, 2021 $68.13M
Sga Expense Q3 2021 · Sep 30, 2020 $16.96M
Sga Expense Q3 2021 · Sep 30, 2020 $53.55M
Rd Expense Q3 2021 · Sep 30, 2021 $61.23M
Rd Expense Q3 2021 · Sep 30, 2021 $173.39M
Rd Expense Q3 2021 · Sep 30, 2020 $54.81M
Rd Expense Q3 2021 · Sep 30, 2020 $151.36M
Net Income Q3 2021 · Sep 30, 2021 −$17.07M
Net Income Q3 2021 · Sep 30, 2021 −$87.85M
Net Income Q3 2021 · Jun 30, 2021 −$40.82M
Net Income Q3 2021 · Mar 31, 2021 −$29.97M
Net Income Q3 2021 · Sep 30, 2020 −$21.85M
Net Income Q3 2021 · Sep 30, 2020 −$76.16M
Net Income Q3 2021 · Jun 30, 2020 −$31.82M
Net Income Q3 2021 · Mar 31, 2020 −$22.49M
Operating Income Q3 2021 · Sep 30, 2021 −$20.27M
Operating Income Q3 2021 · Sep 30, 2021 −$89.62M
Operating Income Q3 2021 · Sep 30, 2020 −$22.9M
Operating Income Q3 2021 · Sep 30, 2020 −$81.56M
Revenue Q3 2021 · Sep 30, 2021 $62.95M
Revenue Q3 2021 · Sep 30, 2021 $151.89M
Revenue Q3 2021 · Sep 30, 2020 $48.88M
Revenue Q3 2021 · Sep 30, 2020 $123.35M